共 32 条
[1]
Zhang A., Sun H., Han Y., Wang X., Chapter 4 - UPLC/MS and its potential in traditional Chinese medicine development, Serum Pharmacochemistry of Traditional Chinese Medicine: Technologies, Strategies and Applications, pp. 23-35, (2017)
[2]
Yang M., Tao S., Guan S., Wu X., Xu P., Guo D., 3.13 - Chinese traditional medicine, Comprehensive Natural Products II: Chemistry and Biology, pp. 383-477, (2010)
[3]
Yan S., Zhao J., Nagle D.G., Zhou Y., Zhang W., Chapter 1 - strategy for modern research of traditional Chinese medicine formulae, Systems Biology and its Application in TCM Formulas Research, pp. 3-18, (2018)
[4]
Wang X., Zhang A., Sun H., Yan G., Wang P., Han Y., Chapter 1 - traditional Chinese medicine: current state, challenges, and applications, Serum Pharmacochemistry of Traditional Chinese Medicine: Technologies, Strategies and Applications, pp. 1-6, (2017)
[5]
Qi Y., Zhang Q., Zhu H., Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations, Chin. Med., 14, 1, (2019)
[6]
Lin L.-T., Wu S.-J., Lin C.-C., The anticancer properties and apoptosis-inducing mechanisms of cinnamaldehyde and the herbal prescription Huang-Lian-Jie-Du-Tang (Huáng Lián Jiě Dú Tang) in human hepatoma cells, J. Tradit. Complementary Med., 3, 4, pp. 227-233, (2013)
[7]
Zhang H., Fu P., Ke B., Wang S., Li M., Han L., Peng C., Zhang W., Liu R., Metabolomic analysis of biochemical changes in the plasma and urine of collagen-induced arthritis in rats after treatment with Huang-Lian-Jie-Du-Tang, J. Ethnopharmacol., 154, 1, pp. 55-64, (2014)
[8]
Ma S., Feng C., Dai G., Song Y., Zhou G., Zhang X., Miao C., Yu H., Ju W., In silico target fishing for the potential bioactive components contained in Huanglian Jiedu Tang (HLJDD) and elucidating molecular mechanisms for the treatment of sepsis, Chin. J. Nat. Med., 13, 1, pp. 30-40, (2015)
[9]
Liao S., Li P., Wang J., Zhang Q., Xu D., Lv Y., Yang M., Kong L., Huang-Lian-Jie-Du decoction treated sepsis via regulating ERK and SRC/STAT3 pathways and ameliorating metabolic status, RSC Adv., 6, 92, pp. 89855-89866, (2016)
[10]
Wei D., Liao S., Wang J., Yang M., Kong L., Cholestatic liver injury model of bile duct ligation and the protection of Huang-Lian-Jie-Du decoction by NMR metabolomic profiling, RSC Adv., 5, 81, pp. 66200-66211, (2015)